Point State Capital LP Global Blood Therapeutics, Inc. Transaction History

Point State Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$31.54 - $46.67 $17.3 Million - $25.6 Million	-548,212 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$38.0 - $51.1 $20.8 Million - $28 Million	548,212 New	548,212 $20.8 Million
Q3 2017 Nov 14, 2017	SELL	$25.1 - $31.05 $7.04 Million - $8.71 Million	-280,479 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	280,479	280,479 $7.67 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Point State Capital LP, based on Form 13F filings with the SEC.

Stay updated on Point State Capital LP with notifications on news.